A Study of EDP-323 in Healthy Subjects
Clinical trial NCT05587478 · COMPLETED
Trial details
- NCT number
- NCT05587478
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-29
- Primary completion
- 2023-03-29
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.